Wait for one more quarter before buying into Aurobindo Pharma: Harendra Kumar

In a chat with ET Now, Harendra Kumar, Managing Director-Institutional Equities, Elara Capital shares his view on Aurobindo Pharma.

ET Now: What about Aurobindo Pharma, it is part of the midcap pharma basket and the common theme here has been excellent set of numbers?

Harendra Kumar: Yes, Aurobindo has been on a comeback of late but obviously the volatility has not been to the comfort of the investor so, probably they will wait for one more quarter before actually they will start to buy into the story. So yes it could be firm but the pop will come only after the next quarter numbers.